Allstate (NYSE:ALL – Get Free Report) had its target price raised by equities research analysts at Wells Fargo & Company from $227.00 to $229.00 in a research report issued on Thursday,Benzinga reports. The firm currently has an “equal weight” rating on the insurance provider’s stock. Wells Fargo & Company‘s target price points to a potential upside of 7.59% from the stock’s current price.
ALL has been the subject of a number of other reports. TD Cowen cut Allstate from a “buy” rating to a “hold” rating in a report on Monday, January 12th. Keefe, Bruyette & Woods boosted their target price on Allstate from $254.00 to $260.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 10th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $220.00 target price on shares of Allstate in a research note on Thursday, February 5th. William Blair cut shares of Allstate from an “outperform” rating to a “market perform” rating in a research report on Thursday, December 18th. Finally, Mizuho decreased their price target on shares of Allstate from $281.00 to $265.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. Three analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $238.65.
View Our Latest Research Report on ALL
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The insurance provider reported $14.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.72 by $5.59. The company had revenue of $17.35 billion during the quarter, compared to the consensus estimate of $17.23 billion. Allstate had a net margin of 15.19% and a return on equity of 39.20%. The firm’s revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $7.67 EPS. Equities research analysts forecast that Allstate will post 18.74 earnings per share for the current year.
Institutional Trading of Allstate
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Truist Financial Corp raised its position in shares of Allstate by 4.7% during the 3rd quarter. Truist Financial Corp now owns 123,461 shares of the insurance provider’s stock valued at $26,501,000 after buying an additional 5,542 shares in the last quarter. Davis Capital Management purchased a new position in Allstate in the third quarter worth about $2,767,000. First Horizon Corp purchased a new position in Allstate in the third quarter worth about $11,109,000. Coastal Bridge Advisors LLC increased its stake in Allstate by 530.6% during the third quarter. Coastal Bridge Advisors LLC now owns 18,174 shares of the insurance provider’s stock worth $3,901,000 after acquiring an additional 15,292 shares during the last quarter. Finally, Jones Financial Companies Lllp increased its stake in Allstate by 6.9% during the third quarter. Jones Financial Companies Lllp now owns 189,718 shares of the insurance provider’s stock worth $40,489,000 after acquiring an additional 12,225 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.
Key Headlines Impacting Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Zacks slightly raised near-term EPS forecasts for Allstate (Q1 estimates nudged higher to ~$6.65–6.68), which modestly improves near-term earnings visibility. Analysts still maintain a “Hold” view, so the change is incremental rather than a re-rating. Zacks Research
- Neutral Sentiment: Barclays bumped its price target slightly from $207 to $208 but kept an “underweight” rating — a small technical move that doesn’t change the sell-side stance and implies limited upside from current levels. Benzinga: Barclays Target Change
- Neutral Sentiment: Market commentary pieces preview Allstate’s upcoming earnings and discuss potential drivers and surprises; useful context for positioning but not new company-specific catalysts. Here’s What to Expect From Allstate’s Next Earnings Report
- Negative Sentiment: Allstate faces a new retaliation lawsuit after an in-house attorney reported alleged bias to HR — this raises reputational and potential legal/settlement risk that could hurt costs and management distraction. Allstate hit with retaliation suit after attorney flags bias to HR
- Negative Sentiment: Zacks moved its rating from “Strong-Buy” to “Hold” — a behavioral negative that can reduce demand from momentum-focused buyers even though EPS estimates were nudged up. Zacks.com
- Negative Sentiment: Ongoing customer claim disputes (example: a driver pushing Allstate to fully cover a highway accident) signal potential reserve/claims exposure and headline risk that can pressure sentiment if similar cases scale. Driver challenging Allstate to fully cover highway accident
Allstate Company Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
See Also
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
